TRAIL protects against endothelial dysfunction in vivo and inhibits angiotensin-II-induced oxidative stress in vascular endothelial cells in vitro
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 126, 341-349
Abstract
No abstract availableKeywords
Funding Information
- Heart Foundation of Australia, Career Development Award
This publication has 57 references indexed in Scilit:
- Angiotensin II and Oxidative Stress in the Failing HeartAntioxidants & Redox Signaling, 2013
- TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKLPLOS ONE, 2013
- Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome PatientsPLOS ONE, 2013
- Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adultsAtherosclerosis, 2011
- Vascular Endothelial Function and Hypertension: Insights and DirectionsCurrent Hypertension Reports, 2010
- Angiotensin II revisited: new roles in inflammation, immunology and agingEMBO Molecular Medicine, 2010
- Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial InfarctionPLOS ONE, 2009
- Prognostic value of apoptosis markers in advanced heart failure patientsEuropean Heart Journal, 2008
- Endothelial cell junctions and the regulation of vascular permeability and leukocyte transmigrationJournal of Thrombosis and Haemostasis, 2008
- Adherens and tight junctions: Structure, function and connections to the actin cytoskeletonBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008